RACHEL ADRIAN: Open Payments
NPI 1548870686 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 26 payments from 8 companies in 2025. Trend: 2023 $82 · 2024 $405 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $215 |
| Stemline Therapeutics Inc. | 3 | $192 |
| Hologic Sales and Service, LLC | 1 | $150 |
| Daiichi Sankyo Inc. | 6 | $128 |
| Napo Pharmaceuticals Inc | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Genentech USA, Inc. | 1 | $19 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $19 |
Products named: KISQALI, Orserdu, APTIMA, Enhertu, GELCLAIR CONCENTRATED ORAL GEL, Phesgo, NERLYNX.
Industry payments across CA — which companies pay providers there.
